An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy

An Engineered M13 Filamentous Nanoparticle as an Antigen Carrier for a Malignant Melanoma Immunotherapeutic Strategy

Bacteriophages, prokaryotic viruses, hold great potential in genetic engineering to open up new avenues for vaccine development. Our study aimed to establish engineered M13 bacteriophages expressing MAGE-A1 tumor peptides as a vaccine for melanoma treatment. Through in vivo experiments, we sought to...

Full description

Bibliographic Details
Main Authors: Nuša Brišar, Katja Šuster, Simona Kranjc Brezar, Robert Vidmar, Marko Fonović, Andrej Cör
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Viruses
Subjects:
nanoparticles
filamentous bacteriophages
phage display technology
bacteriophage-based vaccine
melanoma-associated antigen
malignant melanoma immunotherapy
Online Access:https://www.mdpi.com/1999-4915/16/2/232

Internet

https://www.mdpi.com/1999-4915/16/2/232

Similar Items